Are MDCK Cells Transfected with the Human MRP2 Gene a Good Model of the Human Intestinal Mucosa?
Overview
Affiliations
Purpose: To investigate whether Madin-Darby canine kidney cells transfected with the human MRP2 gene (MDCK-MRP2) are a good model of the human intestinal mucosa.
Methods: MRP2 expression in Caco-2 cells was compared with the expression of this efflux transporter in MDCK-wild type (MDCK-WT) and MDCK-MRP2 cells using Western blotting methods. The polarized efflux activities of MRP2 in the MDCK-MRP2, MDCK-WT. MDCK cells transfected with the human MDR1 gene (MDCK-MDR1), and Caco-2 cells were compared using vinblastine as a substrate. Apparent Michaelis-Menten constants (K(M), Vmax) for the efflux of vinblastine in Caco-2 and MDCK-MRP2 cells were determined in the presence of GF120918 (2 microM), which inhibits P-glycoprotein but does not affect MRP2. Apparent inhibitory constants (K(I)) of known substrates/inhibitors of MRP2 were determined by measuring their effects on the efflux of vinblastine in these cell lines.
Results: MDCK-MRP2 cells expressed higher levels of MRP2 than MDCK-WT and Caco-2 cells as measured by Western blotting technique. Two isoforms of MRP2 expressed in Caco-2 and MDCK cells migrated at molecular weights of 150 kD and 190 kD. In MDCK-MRP2 cells, the 150 kD isoform appeared to be overexpressed. MDCK-MRP2 cell monolayers exhibited higher polarized efflux of vinblastine than Caco-2 and MDCK-WT cell monolayers. K(M) values for vinblastine in Caco-2 and MDCK-MRP2 cells were determined to be 71.8+/-11.6 and 137.3+/-33.6 microM. respectively, and Vmax values were determined to be (0.54+/-0.03 and 2.45+/-0.31 pmolcm(-2)s(-1), respectively. Known substrates/inhibitors of MRP2 showed differences in their ability to inhibit vinblastine efflux in Caco-2 cells as compared to MDCK-MRP2 cells
Conclusions: These data suggest that MDCK-MRP2 cells overexpress only the 150 kD isoform of MRP2. The 190 kD isoform, which was also found in Caco-2 cells and MDCK-WT cells, was present in MDCK-MRP2 cells but not over expressed. The apparent kinetics constants and affinities of some MRP2 substrates were different in Caco-2 cells and MDCK-MRP2 cells. These differences in substrate activity could result from differences in the relative expression levels of the MRP2 isoforms present in Caco-2 cells and MDCK-MRP2 cells and/or differences in the partitioning of substrates in these two cell membrane bilayers.
Knockout Transporter Cell Lines to Assess Substrate Potential Towards Efflux Transporters.
Volpe D AAPS J. 2024; 26(4):79.
PMID: 38981917 DOI: 10.1208/s12248-024-00950-6.
Chunduri V, Maddi S ADMET DMPK. 2023; 11(1):1-32.
PMID: 36778905 PMC: 9909725. DOI: 10.5599/admet.1513.
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients.
Gonzalez-Alvarez I, Sanchez-Dengra B, Rodriguez-Galvez R, Ruiz-Picazo A, Gonzalez-Alvarez M, Garcia-Arieta A Pharmaceutics. 2022; 14(12).
PMID: 36559059 PMC: 9783061. DOI: 10.3390/pharmaceutics14122565.
Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat.
Sanchez-Dengra B, Gonzalez-Alvarez I, Bermejo M, Gonzalez-Alvarez M Pharmaceutics. 2021; 13(9).
PMID: 34575476 PMC: 8471455. DOI: 10.3390/pharmaceutics13091402.
Deng F, Ghemtio L, Grazhdankin E, Wipf P, Xhaard H, Kidron H Mol Pharm. 2020; 17(7):2398-2410.
PMID: 32496785 PMC: 7497665. DOI: 10.1021/acs.molpharmaceut.0c00155.